Integra LifeSciences IART Asia Pacific — Total Revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's asia pacific — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's asia pacific — total revenues?
- Integra LifeSciences (IART) reported asia pacific — total revenues of $45.21M in Q1 2026.
- How has Integra LifeSciences's asia pacific — total revenues changed year-over-year?
- Integra LifeSciences's asia pacific — total revenues increased by 0.2% year-over-year, from $45.11M to $45.21M.
- What is the long-term trend for Integra LifeSciences's asia pacific — total revenues?
- Over 4 years (2021 to 2025), Integra LifeSciences's asia pacific — total revenues has grown at a 1.0% compound annual growth rate (CAGR), from $182.03M to $189.25M.
- What does asia pacific — total revenues mean?
- This metric represents the total net sales generated from products and services sold within the Asia Pacific geographic region. It serves as a key indicator of the company's market penetration, demand, and growth trajectory in these specific international markets. Tracking this revenue stream helps investors assess the effectiveness of regional sales strategies and the company's ability to compete against local and global medical device manufacturers.